Filing Details

Accession Number:
0001209191-16-132076
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-07-07 18:46:09
Reporting Period:
2016-07-05
Filing Date:
2016-07-07
Accepted Time:
2016-07-07 18:46:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1311596 Tobira Therapeutics Inc. TBRA Pharmaceutical Preparations (2834) 030422069
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1388325 A/s Novo Tuborg Havnevej 19
Hellerup G7 2900
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-07-05 10,400 $12.57 2,016,691 No 4 S Direct
Common Stock Disposition 2016-07-06 59,850 $12.20 1,956,841 No 4 S Direct
Common Stock Disposition 2016-07-07 21,869 $12.03 1,934,972 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.50 to $12.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  2. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.12 to $12.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $12.00 to $12.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.